A quantitative comparison of cytosolic delivery via different protein uptake systems

Scientific Reports

Volumn 7, Issue 1, 2017, Pages

  Verdurmen, Wouter P R ^a,b   Mazlami, Marigona ^a   Plückthun, Andreas ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL TOXIN; CELL PENETRATING PEPTIDE; LIGASE;

CYTOSOL; ENDOSOME; METABOLISM; PHYSIOLOGY; PROTEIN TRANSPORT; TRANSPORT AT THE CELLULAR LEVEL;

BACTERIAL TOXINS; BIOLOGICAL TRANSPORT; CARBON-NITROGEN LIGASES; CELL-PENETRATING PEPTIDES; CYTOSOL; ENDOSOMES; PROTEIN TRANSPORT;

EID: 85031787641     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-13469-y     Document Type: Article

References (56)

1. Endoh, T. & Ohtsuki, T. Cellular siRNA delivery using cell-penetrating peptides modified for endosomal escape. Adv. Drug Deliv. Rev. 61, 704-709 (2009).
2. Wadia, J. S., Stan, R. V. & Dowdy, S. F. Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nat. Med. 10, 310-315 (2004).
3. McNaughton, B. R., Cronican, J. J., Thompson, D. B. & Liu, D. R. Mammalian cell penetration, siRNA transfection, and DNA transfection by supercharged proteins. Proc. Natl. Acad. Sci. USA 106, 6111-6116 (2009).
4. Zuris, J. A. et al. Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo. Nat. Biotechnol. 33, 73-80 (2015).
5. Rabideau, A. E. & Pentelute, B. L. Delivery of non-native cargo into mammalian cells using anthrax lethal toxin. ACS Chem. Biol. 11, 1490-1501 (2016).
6. Verdurmen, W. P., Luginbühl, M., Honegger, A. & Plückthun, A. Efficient cell-specific uptake of binding proteins into the cytoplasm through engineered modular transport systems. J. Control. Release 200, 13-22 (2015).
7. Luo, D. & Saltzman, W. M. Synthetic DNA delivery systems. Nat. Biotechnol. 18, 33-37 (2000).
8. Torchilin, V. P. Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery. Nat. Rev. Drug Discov. 13, 813-827 (2014).
9. Vader, P., Mol, E. A., Pasterkamp, G. & Schiffelers, R. M. Extracellular vesicles for drug delivery. Adv. Drug Deliv. Rev. 106, 148-156 (2016).
10. Verdurmen, W. P. R., Mazlami, M. & Plückthun, A. A biotin ligase-based assay for the quantification of the cytosolic delivery of therapeutic proteins. Methods Mol. Biol. 1575, 223-236 (2017).
11. Derossi, D., Joliot, A. H., Chassaing, G. & Prochiantz, A. The third helix of the Antennapedia homeodomain translocates through biological membranes. J. Biol. Chem. 269, 10444-10450 (1994).
12. Vives, E., Brodin, P. & Lebleu, B. A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J. Biol. Chem. 272, 16010-16017 (1997).
13. Foss, F. M., Saleh, M. N., Krueger, J. G., Nichols, J. C. & Murphy, J. R. Diphtheria toxin fusion proteins. Curr. Top. Microbiol. Immunol. 234, 63-81 (1998).
14. Weldon, J. E. & Pastan, I. A guide to taming a toxin-recombinant immunotoxins constructed from Pseudomonas exotoxin A for the treatment of cancer. FEBS J. 278, 4683-4700 (2011).
15. Young, J. A. & Collier, R. J. Anthrax toxin: receptor binding, internalization, pore formation, and translocation. Annu. Rev. Biochem. 76, 243-265 (2007).
16. Wetzel, S. K., Settanni, G., Kenig, M., Binz, H. K. & Plückthun, A. Folding and unfolding mechanism of highly stable full-consensus ankyrin repeat proteins. J. Mol. Biol. 376, 241-257 (2008).
17. Duchardt, F., Fotin-Mleczek, M., Schwarz, H., Fischer, R. & Brock, R. A comprehensive model for the cellular uptake of cationic cell-penetrating peptides. Traffic 8, 848-866 (2007).
18. Guidotti, G., Brambilla, L. & Rossi, D. Cell-penetrating peptides: From basic research to clinics. Trends Pharmacol. Sci. 38, 406-424 (2017).
19. Lundin, P. et al. Distinct uptake routes of cell-penetrating peptide conjugates. Bioconjug. Chem. 19, 2535-2542 (2008).
20. Raucher, D. & Ryu, J. S. Cell-penetrating peptides: strategies for anticancer treatment. Trends Mol. Med. 21, 560-570 (2015).
21. Murphy, J. R. et al. Genetic construction, expression, and melanoma-selective cytotoxicity of a diphtheria toxin-related alpha-melanocyte-stimulating hormone fusion protein. Proc. Natl. Acad. Sci. USA 83, 8258-8262 (1986).
22. Ogata, M., Chaudhary, V. K., FitzGerald, D. J. & Pastan, I. Cytotoxic activity of a recombinant fusion protein between interleukin 4 and Pseudomonas exotoxin. Proc. Natl. Acad. Sci. USA. 86, 4215-4219 (1989).
23. Mechaly, A., McCluskey, A. J. & Collier, R. J. Changing the receptor specificity of anthrax toxin. m Bio 3(3), e00088-12 (2012).
24. Thompson, D. B., Villasenor, R., Dorr, B. M., Zerial, M. & Liu, D. R. Cellular uptake mechanisms and endosomal trafficking of supercharged proteins. Chem. Biol. 19, 831-843 (2012).
25. Cronican, J. J. et al. Potent delivery of functional proteins into mammalian cells in vitro and in vivo using a supercharged protein. ACS Chem. Biol. 5, 747-752 (2010).
26. Winkler, J., Martin-Killias, P., Plückthun, A. & Zangemeister-Wittke, U. EpCAM-Targeted delivery of nanocomplexed siRNA to tumor cells with designed ankyrin repeat proteins. Mol. Cancer Ther. 8, 2674-2683 (2009).
27. Simon, M., Stefan, N., Plückthun, A. & Zangemeister-Wittke, U. Epithelial cell adhesion molecule-Targeted drug delivery for cancer therapy. Expert Opin. Drug Deliv. 10, 451-468 (2013).
28. Tsaktanis, T. et al. Cleavage and cell adhesion properties of human epithelial cell adhesion molecule (HEPCAM). J. Biol. Chem. 290, 24574-24591 (2015).
29. Holliday, D. L. & Speirs, V. Choosing the right cell line for breast cancer research. Breast Cancer Res. 13, 215 (2011).
30. Zhang, L. et al. HER2-Targeting recombinant protein with truncated pseudomonas exotoxin A translocation domain efficiently kills breast cancer cells. Cancer Biol. Ther. 7, 1226-1231 (2008).
31. Safari, E. et al. Cytotoxic effect of immunotoxin containing the truncated form of Pseudomonas exotoxin A and anti-VEGFR2 on HUVEC and MCF-7 cell lines. Cell J. 16, 203-210 (2014).
32. Heimbrook, D. C. et al. Transforming growth factor alpha-Pseudomonas exotoxin fusion protein prolongs survival of nude mice bearing tumor xenografts. Proc. Natl. Acad. Sci. USA. 87, 4697-4701 (1990).
33. Daniels, T. R. et al. The transferrin receptor and the targeted delivery of therapeutic agents against cancer. Biochim. Biophys. Acta 1820, 291-317 (2012).
34. McCluskey, A. J., Olive, A. J., Starnbach, M. N. & Collier, R. J. Targeting HER2-positive cancer cells with receptor-redirected anthrax protective antigen. Mol. Oncol. 7, 440-451 (2013).
35. Lohcharoenkal, W. et al. Potent enhancement of GFP uptake into HT-29 cells and rat skin permeation by coincubation with tat peptide. J. Pharm. Sci. 100, 4766-4773 (2011).
36. Holm, T. et al. Retro-inversion of certain cell-penetrating peptides causes severe cellular toxicity. Biochim. Biophys. Acta 1808, 1544-1551 (2011).
37. Koppelhus, U. et al. Cell-dependent differential cellular uptake of PNA, peptides, and PNA-peptide conjugates. Antisense Nucleic Acid Drug Dev. 12, 51-63 (2002).
38. Layek, B. & Singh, J. Cell penetrating peptide conjugated polymeric micelles as a high performance versatile nonviral gene carrier. Biomacromolecules 14, 4071-4081 (2013).
39. Mohammed, A. F. et al. The Pseudomonas aeruginosa exotoxin A translocation domain facilitates the routing of CPP-protein cargos to the cytosol of eukaryotic cells. J. Control. Release 164, 58-64 (2012).
40. Stefan, N. et al. DARPins recognizing the tumor-Associated antigen EpCAM selected by phage and ribosome display and engineered for multivalency. J. Mol. Biol. 413, 826-843 (2011).
41. Schembri, L. et al. The HA tag is cleaved and loses immunoreactivity during apoptosis. Nat. Methods 4, 107-108 (2007).
42. Erazo-Oliveras, A., Muthukrishnan, N., Baker, R., Wang, T. Y. & Pellois, J. P. Improving the endosomal escape of cell-penetrating peptides and their cargos: strategies and challenges. Pharmaceuticals (Basel) 5, 1177-1209 (2012).
43. Lönn, P. & Dowdy, S. F. Cationic PTD/CPP-mediated macromolecular delivery: charging into the cell. Expert Opin. Drug Deliv. 12, 1627-1636 (2015).
44. Lönn, P. et al. Enhancing endosomal escape for intracellular delivery of macromolecular biologic therapeutics. Sci. Rep. 6, 32301 (2016).
45. Salerno, J. C. et al. Novel cell-penetrating peptide-Adaptors effect intracellular delivery and endosomal escape of protein cargos. J. Cell Sci. 129, 893-897 (2016).
46. Li, M. et al. Discovery and characterization of a peptide that enhances endosomal escape of delivered proteins in vitro and in vivo. J. Am. Chem. Soc. 137, 14084-14093 (2015).
47. de Godoy, L. M. et al. Comprehensive mass-spectrometry-based proteome quantification of haploid versus diploid yeast. Nature 455, 1251-1254 (2008).
48. Zorko, M. & Langel, Ü. Cell-penetrating peptides: mechanism and kinetics of cargo delivery. Adv. Drug Deliv. Rev. 57, 529-545 (2005).
49. Fu, A., Tang, R., Hardie, J., Farkas, M. E. & Rotello, V. M. Promises and pitfalls of intracellular delivery of proteins. Bioconjug. Chem. 25, 1602-1608 (2014).
50. Varkouhi, A. K., Scholte, M., Storm, G. & Haisma, H. J. Endosomal escape pathways for delivery of biologicals. J. Control. Release 151, 220-228 (2011).
51. Wedekind, J. E. et al. Refined crystallographic structure of Pseudomonas aeruginosa exotoxin A and its implications for the molecular mechanism of toxicity. J. Mol. Biol. 314, 823-837 (2001).
52. Bennett, M. J. & Eisenberg, D. Refined structure of monomeric diphtheria toxin at 2.3 Å resolution. Protein Sci. 3, 1464-1475 (1994).
53. Petosa, C., Collier, R. J., Klimpel, K. R., Leppla, S. H. & Liddington, R. C. Crystal structure of the anthrax toxin protective antigen. Nature 385, 833-838 (1997).
54. Pannifer, A. D. et al. Crystal structure of the anthrax lethal factor. Nature 414, 229-233 (2001).
55. Ormo, M. et al. Crystal structure of the Aequorea victoria green fluorescent protein. Science 273, 1392-1395 (1996).
56. Kramer, M. A., Wetzel, S. K., Plückthun, A., Mittl, P. R. & Grütter, M. G. Structural determinants for improved stability of designed ankyrin repeat proteins with a redesigned C-capping module. J. Mol. Biol. 404, 381-391 (2010).